Wolfgang Bönigk

Title: Wolfgang Bönigk: Innovator in Cardiovascular Research

Introduction

Wolfgang Bönigk is a notable inventor based in Juelich, Germany. He has made significant contributions to the field of cardiovascular research through his innovative work in nucleic acids and ion channels. With a total of 2 patents, Bönigk's inventions are paving the way for advancements in medical treatments.

Latest Patents

Bönigk's latest patents focus on isolated or purified human nucleic acids, particularly DNA that encodes ion channels. One of his inventions relates to a vector that includes the isolated nucleic acid, a host cell containing the vector, and a composition that combines the nucleic acid with a carrier. This invention also encompasses a polypeptide or protein encoded by the nucleic acid, along with methods for treating mammals suffering from cardiovascular disorders. Another patent involves a nucleic acid that comprises a portion of the sequence of an ion channel, which may be derived from various species, including humans and sea urchins. This invention also includes an mRNA molecule containing the corresponding sequences and highlights the use of these nucleic acids and proteins for screening, diagnosing methods, and treatment of cardiovascular disorders.

Career Highlights

Wolfgang Bönigk is associated with Forschungszentrum Jülich GmbH, where he continues to contribute to groundbreaking research. His work has been instrumental in advancing the understanding of cardiovascular disorders and developing potential treatments.

Collaborations

Bönigk collaborates with esteemed colleagues, including Renate Gauss and Alexander Scholten, to further enhance the impact of his research in the scientific community.

Conclusion

Wolfgang Bönigk's innovative contributions to cardiovascular research through his patents demonstrate his commitment to advancing medical science. His work is essential for developing new treatments and understanding complex biological processes.